CIBC Bancorp USA’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.2M Buy
540,258
+475,857
+739% +$34.3M 0.05% 294
2026
Q2
$4.55M Sell
64,401
-1,938
-3% -$105K 0.01% 782
2026
Q1
$3.47M Buy
+66,339
New +$3.98M ﹤0.01% 799
2025
Q3
$890K Buy
+16,007
New +$857K ﹤0.01% 702

Other funds holding TECH

CIBC Bancorp USA's TECH Position: Q3 2026 in Review

CIBC Bancorp USA increased its Bio-Techne (TECH) stake by 739% in Q3 2026, buying an estimated $34.3M and bringing the position to 540,258 shares worth $39.2M. The position accounts for 0.05% of the portfolio, ranked #294.

CIBC Bancorp USA first reported a position in TECH in Q3 2025 and has held it in 4 quarters since. 583 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • CIBC Bancorp USA held 540,258 shares of Bio-Techne worth $39.2M as of Q3 2026.
  • CIBC Bancorp USA bought 475,857 Bio-Techne shares in Q3 2026, an estimated $34.3M.
  • Bio-Techne made up 0.05% of CIBC Bancorp USA's portfolio in Q3 2026, its #294 holding.
  • CIBC Bancorp USA first reported a position in Bio-Techne in Q3 2025 and has held it in 4 quarters since.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.